Cabot - CBT Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CBT shares.
View CBT analyst ratings or view top-rated stocks.

4 Wall Street research analysts have issued 12-month price targets for Cabot's stock. Their CBT share price forecasts range from $87.00 to $113.00. On average, they expect the company's share price to reach $96.00 in the next twelve months. This suggests a possible upside of 27.7% from the stock's current price.
View analysts price targets for CBT or view top-rated stocks among Wall Street analysts.

Cabot's stock was trading at $66.84 on January 1st, 2023. Since then, CBT shares have increased by 12.5% and is now trading at $75.19.
View the best growth stocks for 2023 here.

Cabot saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 855,100 shares, an increase of 18.9% from the February 28th total of 719,300 shares. Based on an average trading volume of 296,300 shares, the days-to-cover ratio is currently 2.9 days. Approximately 1.5% of the shares of the stock are sold short.
View Cabot's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 1st 2023.
View our CBT earnings forecast.

Cabot Co. (NYSE:CBT) issued its quarterly earnings results on Friday, February, 10th. The specialty chemicals company reported $0.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.02. The specialty chemicals company had revenue of $965 million for the quarter, compared to the consensus estimate of $955.24 million. Cabot had a net margin of 8.15% and a trailing twelve-month return on equity of 32.03%. The firm's revenue for the quarter was down .3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.29 EPS.

Cabot declared a quarterly dividend on Friday, January 13th. Shareholders of record on Friday, February 24th will be paid a dividend of $0.37 per share on Friday, March 10th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 1.97%. The ex-dividend date is Thursday, February 23rd.
Read our dividend analysis for CBT.

ETFs with the largest weight of Cabot (NYSE:CBT) stock in their portfolio include ProShares Smart Materials ETF (TINT), ProShares Nanotechnology ETF (TINY), Invesco DWA Basic Materials Momentum ETF (PYZ), Global X Autonomous & Electric Vehicles ETF (DRIV), Invesco S&P MidCap 400 Pure Growth ETF (RFG), Invesco S&P MidCap Momentum ETF (XMMO), First Trust Mid Cap Growth AlphaDEX Fund (FNY) and Fidelity Women's Leadership ETF (FDWM).

Cabot (NYSE:CBT) pays an annual dividend of $1.48 per share and currently has a dividend yield of 2.02%. The dividend payout ratio is 24.26%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CBT will have a dividend payout ratio of 23.95% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CBT.

Cabot updated its FY23 earnings guidance on Thursday, February, 9th. The company provided EPS guidance of $6.25-$6.75 for the period, compared to the consensus earnings per share estimate of $6.51.

40 employees have rated Cabot Chief Executive Officer Sean Keohane on Glassdoor.com. Sean Keohane has an approval rating of 96% among the company's employees. This puts Sean Keohane in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Pfizer (PFE), Broadcom (AVGO), Energy Transfer (ET), AT&T (T), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Coca-Cola (KO).

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

Cabot's stock is owned by many different retail and institutional investors. Top institutional shareholders include Earnest Partners LLC (5.53%), Fuller & Thaler Asset Management Inc. (3.75%), Bank of America Corp DE (2.51%), Dimensional Fund Advisors LP (2.32%), Geode Capital Management LLC (1.78%) and Barrow Hanley Mewhinney & Strauss LLC (1.32%). Insiders that own company stock include Hobart Kalkstein, Karen A Kalita, Karen A Kalita and Sean D Keohane.
View institutional ownership trends.

Shares of CBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CBT stock can currently be purchased for approximately $75.19.

Cabot (NYSE:CBT) has a market capitalization of $4.23 billion and generates $4.32 billion in revenue each year. The specialty chemicals company earns $209 million in net income (profit) each year or $6.10 on an earnings per share basis.

The company employs 4,200 workers across the globe.

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The official website for the company is www.cabot-corp.com. The specialty chemicals company can be reached via phone at (617) 345-0100, via email at steve.delahunt@cabotcorp.com, or via fax at 617-342-6103.